Commercial Momentum Presentation
Filed with ASX · · 22 pages · English
Summary by 6ix AI
The presentation emphasizes the successful adoption of its NeuroNode technology in assistive communication and the expansion into sports performance and rehabilitation markets. Control Bionics is also focusing on integrating its technology with major partners like Apple to enhance its offerings and reach new markets.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
In the deck
Earlier from Control Bionics
- German Statutory Reimbursement Listing for NeuroNode
- Joint venture with NextLevel Assistive Technology
- Half Yearly Report and Accounts
- PRC-Saltillo - Distribution Agreement
- Quarterly Activities/Appendix 4C Cash Flow Report
Later from Control Bionics
- Pause in Trading
- Completion of Placement
- Commercial momentum builds across both platform pillars
- US FDA Registration and Device Listing for NeuroStrip
- NeuroStrip secures MHRA registration
Follow Control Bionics into a list and get an email when it puts out news.
Follow Control Bionics